The company was founded in 2013 and conducts scientific research in the field of life sciences and technical sciences.
The company’s projects:
- R&D with the participation of scientists from the Medical University of Lublin and the Lublin University of Technology.
- „Droplet” – a device designed to detect early signs of Alzheimer’s disease by measuring the seismic mass of a blood drop.
- „Bioxee” – screening for cardiovascular disease using Big Data and AI components; also designed for personal monitoring of patients.